Pancreatic Cancer Research

ResearcherAlbert Einstein College of MedicineActive in the last 2 years

Sanjay Goel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2798-7568; OpenAlex author ID A5029455802. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 5

  1. Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma. Last author DOI 10.1158/1078-0432.ccr-24-3149↗
  2. Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-24-1164↗
  3. Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/10732748221134411↗
  4. The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer. Last author DOI 10.1007/s12029-019-00316-8↗
  5. A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma. First author DOI 10.3390/cancers10060160↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Harshabad Singh · 2 shared papers, 2024–2025 · strength 0.36
  2. Rachna T. Shroff · 2 shared papers, 2024–2025 · strength 0.36
  3. Andrew J. Aguirre · 2 shared papers, 2024–2025 · strength 0.36
  4. Michael Jon Pishvaian · 2 shared papers, 2024–2025 · strength 0.36
  5. Jennifer W. Chuy · 2 shared papers, 2020–2022 · strength 0.25
  6. Andreas Kaubisch · 2 shared papers, 2020–2022 · strength 0.25
  7. Bach Ardalan · 1 shared paper, 2025 · strength 0.21
  8. Emil Lou · 1 shared paper, 2025 · strength 0.21
  9. Anup Kasi · 1 shared paper, 2025 · strength 0.21
  10. Anthony Frank Shields · 1 shared paper, 2025 · strength 0.21
  11. Aaron Ciner · 1 shared paper, 2025 · strength 0.21
  12. Jashodeep Datta · 1 shared paper, 2025 · strength 0.21
  13. Chen Yuan · 1 shared paper, 2024 · strength 0.15
  14. Srivatsan Raghavan · 1 shared paper, 2024 · strength 0.15
  15. Rishi Surana · 1 shared paper, 2024 · strength 0.15
  16. David B. Spetzler · 1 shared paper, 2024 · strength 0.15
  17. Hannah L. Williams · 1 shared paper, 2024 · strength 0.15
  18. Andressa Dias Costa · 1 shared paper, 2024 · strength 0.15
  19. Brian Matthew Wolpin · 1 shared paper, 2024 · strength 0.15
  20. Brandon M. Huffman · 1 shared paper, 2024 · strength 0.15
  21. Benjamin Adam Weinberg · 1 shared paper, 2024 · strength 0.15
  22. Jonathan Andrew Nowak · 1 shared paper, 2024 · strength 0.15
  23. Kimberly J. Perez · 1 shared paper, 2024 · strength 0.15
  24. Stephanie K. Dougan · 1 shared paper, 2024 · strength 0.15
  25. James M. Cleary · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.